This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Bioactive Regenerative Therapeutics, Inc., Regents of the University of Minnesota. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2020
Title: John H Brekke: Innovator in Biomimetic Hybrid Gel Compositions
Introduction
John H Brekke is a notable inventor based in Two Harbors, MN (US). He has made significant contributions to the field of biomimetic materials, particularly in the development of hybrid gel compositions. With a total of 2 patents, Brekke's work focuses on innovative solutions for medical applications.
Latest Patents
Brekke's latest patents include advancements in biomimetic hybrid gel compositions and methods of use. These patents disclose dry blends of polyanionic and polycationic macromolecules, along with solvating fluids that serve as cell suspension fluids. The hybrid gel compositions are designed for the treatment of patients with endocrine disorders through transplantation. They promote a microenvironment that is suitable for cell viability and growth while maintaining sufficient structural integrity for three-dimensional cell culture.
Career Highlights
Throughout his career, John H Brekke has worked with various organizations, including Bioactive Regenerative Therapeutics, Inc. and the Regents of the University of Minnesota. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of regenerative medicine.
Collaborations
Brekke has collaborated with notable individuals such as Timothy David O'Brien and Timothy O'brien. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
John H Brekke's contributions to the field of biomimetic hybrid gel compositions highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the landscape of regenerative medicine and offers promising solutions for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile